Preparation of Y₂O₃ nanoparticulate thin films using an emulsion liquid membrane systemHIRAI, Takayuki; KAWAMURA, Yusuke; KOMASAWA, Isao et al.Journal of colloid and interface science. 2004, Vol 275, Num 2, pp 508-513, issn 0021-9797, 6 p.Article

Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patientsONO, Atsushi; SUZUKI, Fumitaka; IKEDA, Kenji et al.Journal of hepatology. 2012, Vol 57, Num 3, pp 508-514, issn 0168-8278, 7 p.Article

Sustained virological response in a patient with chronic hepatitis C treated by monotherapy with the NS3-4A protease inhibitor telaprevirSUZUKI, Fumitaka; SUZUKI, Yoshiyuki; SAITO, Satoshi et al.Journal of clinical virology. 2010, Vol 47, Num 1, pp 76-78, issn 1386-6532, 3 p.Article

Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in japanese patients infected with hepatitis C virus genotype 1bAKUTA, Norio; SUZUKI, Fumitaka; IKEDA, Kenji et al.Journal of medical virology. 2007, Vol 79, Num 11, pp 1686-1695, issn 0146-6615, 10 p.Article

Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis CARASE, Yasuji; IKEDA, Kenji; KOBAYASHI, Mariko et al.Journal of medical virology. 2007, Vol 79, Num 8, pp 1095-1102, issn 0146-6615, 8 p.Article

Diabetes Enhances Hepatocarcinogenesis in Noncirrhotic, Interferon-treated Hepatitis C PatientsKAWAMURA, Yusuke; ARASE, Yasuji; SUZUKI, Fumitaka et al.The American journal of medicine. 2010, Vol 123, Num 10, pp 951-956, issn 0002-9343, 6 p.Article

Virus Clearance Reduces Bone Fracture in Postmenopausal Women With Osteoporosis and Chronic Liver Disease Caused by Hepatitis C VirusARASE, Yasuji; SUZUKI, Fumitaka; IKEDA, Kenji et al.Journal of medical virology. 2010, Vol 82, Num 3, pp 390-395, issn 0146-6615, 6 p.Article

Losartan Reduces the Onset of Type 2 Diabetes in Hypertensive Japanese Patients With Chronic Hepatitis CARASE, Yasuji; SUZUKI, Fumitaka; SAITO, Satoshi et al.Journal of medical virology. 2009, Vol 81, Num 9, pp 1584-1590, issn 0146-6615, 7 p.Article

Sustained Virological Response Reduces Incidence of Onset of Type 2 Diabetes in Chronic Hepatitis CARASE, Yasuji; SUZUKI, Fumitaka; IKEDA, Kenji et al.Hepatology (Baltimore, Md.). 2009, Vol 49, Num 3, pp 739-744, issn 0270-9139, 6 p.Article

Efficacy of Low-Dose Intermittent Interferon-Alpha Monotherapy in Patients Infected With Hepatitis C Virus Genotype 1b Who Were Predicted or Failed to Respond to Pegylated Interferon Plus Ribavirin Combination TherapyAKUTA, Norio; SUZUKI, Fumitaka; IKEDA, Kenji et al.Journal of medical virology. 2008, Vol 80, Num 8, pp 1363-1369, issn 0146-6615, 7 p.Article

Emergence of Telaprevir-Resistant Variants Detected by Ultra-Deep Sequencing After Triple Therapy in Patients Infected With HCV Genotype 1AKUTA, Norio; SUZUKI, Fumitaka; SAITOH, Satoshi et al.Journal of medical virology. 2013, Vol 85, Num 6, pp 1028-1036, issn 0146-6615, 9 p.Article

Association of IL28B Genotype and Viral Response of Hepatitis C Virus Genotype 2 to Interferon Plus Ribavirin Combination TherapyAKUTA, Norio; SUZUKI, Fumitaka; ARASE, Yasuji et al.Journal of medical virology. 2012, Vol 84, Num 10, pp 1593-1599, issn 0146-6615, 7 p.Article

Previous Chemoembolization Response after Transcatheter Arterial Chemoembolization (TACE) Can Predict the Anti-Tumor Effect of Subsequent TACE with Miriplatin in Patients with Recurrent Hepatocellular CarcinomaIMAI, Norihiro; IKEDA, Kenji; SUZUKI, Yoshiyuki et al.Oncology. 2011, Vol 80, Num 3-4, pp 188-194, issn 0030-2414, 7 p.Article

Amino Acid Substitution in Hepatitis C Virus Core Region and Genetic Variation Near the Interleukin 28B Gene Predict Viral Response to Telaprevir with Peginterferon and RibavirinAKUTA, Norio; SUZUKI, Fumitaka; SAITOH, Satoshi et al.Hepatology (Baltimore, Md.). 2010, Vol 52, Num 2, pp 421-429, issn 0270-9139, 9 p.Article

A Matched Case-Controlled Study of 48 and 72 Weeks of Peginterferon Plus Ribavirin Combination Therapy in Patients Infected With HCV Genotype 1b in Japan : Amino Acid Substitutions in HCV Core Region as Predictor of Sustained Virological ResponseAKUTA, Norio; SUZUKI, Fumitaka; SAITOH, Satoshi et al.Journal of medical virology. 2009, Vol 81, Num 3, pp 452-458, issn 0146-6615, 7 p.Article

Development of hepatocellular carcinoma in elderly patients with chronic hepatitis C with or without elevated aspartate and alanine aminotransferase levelsKOBAYASHI, Mariko; SUZUKI, Fumitaka; IKEDA, Kenji et al.Scandinavian journal of gastroenterology. 2009, Vol 44, Num 8, pp 975-983, issn 0036-5521, 9 p.Article

Influence of ITPA Polymorphisms on Decreases of Hemoglobin During Treatment with Pegylated Interferon, Ribavirin, and TelaprevirSUZUKI, Fumitaka; SUZUKI, Yoshiyuki; IKEDA, Kenji et al.Hepatology (Baltimore, Md.). 2011, Vol 53, Num 2, pp 415-421, issn 0270-9139, 7 p.Article

Amino Acid Substitutions in the Hepatitis C Virus Core Region of Genotype 1b Affect Very Early Viral Dynamics During Treatment With Telaprevir, Peginterferon, and RibavirinAKUTA, Norio; SUZUKI, Fumitaka; SAITOH, Satoshi et al.Journal of medical virology. 2010, Vol 82, Num 4, pp 575-582, issn 0146-6615, 8 p.Article

Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patientsSUZUKI, Fumitaka; AKUTA, Norio; SAITOH, Satoshi et al.Journal of gastroenterology and hepatology. 2010, Vol 25, Num 5, pp 892-898, issn 0815-9319, 7 p.Article

Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years : Histological improvement or entecavir resistance?SUZUKI, Yoshiyuki; SUZUKI, Fumitaka; IKEDA, Kenji et al.Journal of gastroenterology and hepatology. 2009, Vol 24, Num 3, pp 429-435, issn 0815-9319, 7 p.Article

High Serum Des-gamma-carboxy Prothrombin Level Predicts Poor Prognosis After Radiofrequency Ablation of Hepatocellular CarcinomaKOBAYASHI, Masahiro; IKEDA, Kenji; ARASE, Yasuji et al.Cancer. 2009, Vol 115, Num 3, pp 571-580, issn 0008-543X, 10 p.Article

Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy : Two-year follow-upYATSUJI, Hiromi; SUZUKI, Fumitaka; IKEDA, Kenji et al.Journal of hepatology. 2008, Vol 48, Num 6, pp 923-931, issn 0168-8278, 9 p.Article

Prolonged-Efficacy of Bisphosphonate in Postmenopausal Women With Osteoporosis and Chronic Liver DiseaseARASE, Yasuji; SUZUKI, Fumitaka; KUMADA, Hiromitsu et al.Journal of medical virology. 2008, Vol 80, Num 7, pp 1302-1307, issn 0146-6615, 6 p.Article

Selection of a virus strain resistant to entecavir in a nucleoside-naive patient with hepatitis B of genotype HSUZUKI, Fumitaka; AKUTA, Norio; KOBAYASHI, Mariko et al.Journal of clinical virology. 2007, Vol 39, Num 2, pp 149-152, issn 1386-6532, 4 p.Article

Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis BARASE, Yasuji; IKEDA, Kenji; KOBAYASHI, Mariko et al.Journal of medical virology. 2007, Vol 79, Num 9, pp 1286-1292, issn 0146-6615, 7 p.Article